{"ticker": {"uuid": "43752eb5-40ca-4e9b-a038-0d826bf6ceb7", "symbol": "PYC", "name": "PYC Therapeutics Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "PYC Therapeutics (ASX:PYC) Eases While Holding on to Positive One-Year Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQM3FXb3c4OHFPZjFaRWhKRTJOUGxIcHhUT3VTYUVIbzRvWFpDWWVCdlFsb2lSZDZVVlotUXBERU1lWHc3MVRfam41RkxyV3gtZ2s4Y19hck1pdEI5WGxsSTNodmNpb0hWZGdwRmgweUtQY0E5N2NLanM5bGZsb1dGU2lyTFJrcURmWF8zdGJGX0pjVF9kZ25qN1RXM3lsM2xCYkNZRUpTWjZ6S0NwZlJEU2ltZ1Q?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T10:09:00+00:00", "published_display": "14 Jul 2026 10:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC) Slips as Investors Assess the Emerging RNA-Therapeutics Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOE1kY29pX01CTnZzN0VfcnlsZmxodjEwTFZJeHprNFdFc3RWTFhpV182clNDVFk2NDN5bHBEWkpCM1UtQ3dqSk8zSjQ4NTZmNzFTcG1mUVZuazdTRzBqb05sVUNxdXpKdUJCZ1ZLYjBBRDJvckZEVU95b05pTHZYaGZ1c2ZSYVNxXzNtNUlwUlpFaWc0SnlZN0NkSlhTZWNqRGsxZE9rSjA0VEI4LVhybkE3MS0xeXdiaTFsWWQ4d1Y0dw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:16:00+00:00", "published_display": "13 Jul 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC) Names New CFO As Investors Weigh A Pricey Valuation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T23:26:17+00:00", "published_display": "11 Jul 2026 23:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PYC Therapeutics Limited \u2013 ASX:PYC", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQWkQ1akdrQTNCNTVLM3NyZU1JYlZkUnFmN1MxdWxIMzFpNVQwOWRiaWZ2clplUlhSR3VwaU1kZ1hqWFpMV3QxMGoxbmJXNDhqV244NzA5VHN6dVdOWUFYWDVWdG9Hd3JIa0VHaG16ZWNlc0I4aHhwVDhueXlxNlU1eGxVTzdvV3Z0T0FuYW04Yk9VNmJUTF8wT3dmVWM?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T19:24:55+00:00", "published_display": "09 Jul 2026 19:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can PYC Therapeutics (ASX:PYC) Strengthen Its Growth Strategy With a New CFO?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNDFPWFBmX2czSGRubE5JdkdOZXhRdFVnekZHWVVWLWtwcVRPZkI2MmVjMGFoMFc5R1pIUU56dVl3ZkwtVWNUTWtNYVE3VHJ3V3h3WDZIdU1kaWhpYWMtZ1ZHX0l0bW5YT1VmNXFqVkZ2d2dSV3JKRFVLVUFxN0NVR1NjSlptY2VSeHJpXzJ5aFhTaU16Y3QzaFRSZGJOU2N2OHF0ZGJuczVkY0wzcmJJa1RsaWswRUlPRFZN?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-09T03:59:00+00:00", "published_display": "09 Jul 2026 03:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will PYC Therapeutics\u2019 New CFO Shift Its Capital-Market Ambitions Up a Gear (ASX:PYC)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T16:36:12+00:00", "published_display": "08 Jul 2026 16:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyc Therapeutics Limited Announces Appointment of Thomas Ulmer as Chief Financial Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPQzdOdmQ1aXVQVHRiN0tFVzZBWDBaMk1uRHFQLTdWZGVkWk5jZEFuWEhqQTl6RURDOWZ1LVNJaU5tcFREbnEzcUREdGJFOFpZSkN3QThNMmpTT05oNUZkc1gwNl9pYjZzN2dLUElUcTJzc0JGZWJuYUdVVFREeGhscjAwVkl1STZveDZUQkZ3U3NlNDkyYkNoaFRnLW5jTjlJYmdmYWtYdGtNSExoekRRTlp0LVZjeXJfbGFjUmVXaUVQVW45elFwX0ItMnY1al9XTG5UR0xmRHd3Zw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-06T22:21:00+00:00", "published_display": "06 Jul 2026 22:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC) Shares Ease Lower Amid Biotech Sector Watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQ1UxZlhfMk1LVlpQREh0akNTR2pORmNYcE9qZ1pac1hEUVNzU1FNNUp6TVJ4dVVpMXJaM1hRREJLQS1WN0t6SnNCc0c1ZEwxTlNySGZPMXc5M2NpU2xHNTlicE1KNXJKLVJQZHRieGItNVVseDI3QVZ6UlBHMkp5MGhLajlEa3ZKRWRtMW9jUFpWUmhQeC02eUo1Z1J3Y3Z1eWlnODRIMlNzZw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics Limited Actuals & Estimates (ASX:PYC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPQ1k3aDB4QnNuckVfQzd1cmtDVm1ZOTlDdUZSOEE2X2xMandRWGlsM0R3MnNPN0tFWkExeVdDbE9Zc3VQWXV1MXloMDZvQzVYcU5IeWhCam9pa1ZxOHNaZ3NwZTZvYWVMNkY2ak4tZXEtQ0ctOWtObjJGRFlxczI1Ug?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T17:43:44+00:00", "published_display": "25 Jun 2026 17:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pleasing Signs As A Number Of Insiders Buy PYC Therapeutics Stock", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics Announces Company Secretary Changes, Effective June 15, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPRktmeEQtREZrV3RReV81dzdxNmVlMWFxYllOX0FRSjA0Z2l6Q0h0SUMwVktodjN0OFhBZk9iSUI1ZlF3Ny1tUkpaNUs2UUk1WjY2R3F4WHA3bWhPbVBzYUc4TngxN0NUcmJaLTFueUpwOHZGRm80QW9KNGNDRG13a2M1U2dSNjJQb0NfTGxDTENvcUdldHFNYVNueTFva0EzU3RQZVUxQlQtRjlfUmE4S0dzTDNXNVVaLUdUbXhXc2tURXpCbUFJ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics H1 2026 Losses Highlight Ongoing Investment And Test Bullish Profitability Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC): Its been raising ~$650m to fund 4 clinical assets for multiple years!", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPOTlQcUtjQ3QyaEVOMTJUemdXTGNHcngxaVpiQUhfWkg3LXcxekdtb19FN1hFSVBxOHNFS0F1c0V5UWk0U2wyOXItZTFOVHVMZDktU21lOGhhYldYOWJYOGdIOGRTbE81TTZqTklkR3g1VWVUVnF0ZkpQcERGUWVDaDh0SEpTN2VpX21HWWQzMXBCTi10N24yWDdCLUVxckxiM2g4WjJ1NGM3OVZXWUtObmV0MWx6TG12X0dj?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC\u2019s capital raise marks one of the largest biotech fundraisings in Australian market history", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNQTBIMi1NZC05YjE5QXVyeDJHVVRvS3dOVjdEWElBNkdhN3B1WWNzdzdKcUx0V1Z5MGZvVU1DNDFFX3JTS1A4R01nelRyOXFzVEQ2RVUzZmxWd09yZWZYRXptV3hwaE4wZGNMUlBzMDhsbFRuNFlLMWRWMWpVN2tlV09zZUs3LWM5MnlrVzdCcjFiYWZZcGVnNDdUT3d2aDBNX2RtLXV3eHVBV0hSSklSbGM5S2xpX0s1cEwzaUx5YUJZLVFNeF9VRw?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics launches $600m-plus cash call, hires two banks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPMURPOE1xbGxBaVhGR0I3TnhFVm1lQXR0bFpHSHlHc1dIZURCZm9QVkFzWmVCdS12T1kwSWxuZlg5Q01ac241bnhsVHQyTHZ2dm5pRVozYXFKUUowRnByaWtBMjZjR1o3d3N2SzQ5YmNfU3FUZmNlOE8zMy1EVXdhX0paWWNObjI5enNxdWFiT0JRTU5nZGwwc0ZGMU5kd2dGbEd5RTZWSVJRdw?oc=5", "source_name": "AFR", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Check: PYC Therapeutics kicks off monster $650m capital raising", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQamtrUVpKTFRfY0tpbVFSM2djSFJsdVMxa2FvczY5YXhzVkd5Z1k5aU1JaDJoZjhQVDYtbGNFYk1uTmw1UGxrV19COTYteGU4TnJLVW9vMHBORzJ4SkhWZHExMnNVZFB0RlU1SUVWanBzUERlRkdkQ2VjLVhqVTBLam1CMlQxWG9WblFzdXc0cVktWnEyVWVFdWpPOUdYZU5sMFVrc2oxQzlMRzNp?oc=5", "source_name": "Stockhead", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Stock Price and Chart \u2014 ASX:PYC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBmTENuNnhmckUxSE00cExZQzVRamNaVDZ1bjVjX0JrZzJ4cFpkSlhGeFpQc3pYWHBiaVY4eS1HcXpRNVBIWDE2U1pzVXkxbEVpQThvN21fSQ?oc=5", "source_name": "TradingView", "published_at": "2026-01-24T08:00:00+00:00", "published_display": "24 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "When Will PYC Therapeutics Limited (ASX:PYC) Become Profitable?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPemktMUwwQW90OWZiamtsdmFocVlUeldnalVlOG9ka3owZklpNFRGQnZ6SGxEc3ZKVmh1cGRKb1E1a194ZVlvdF9CMGFXSFJWSUQ0NmtGd0dPTzBvRGtsM0h5UFZZTzUzRVR2OU9MQjNwcUlnNjdfeHI3THV3dXJCY0VKLTk?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Breakeven On The Horizon For PYC Therapeutics Limited (ASX:PYC)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-24T08:00:00+00:00", "published_display": "24 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why PYC Therapeutics (ASX:PYC) Is Down 14.4% After Sudden CEO Exit and Board Reshuffle", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBXTVJPWFpoNWhHcVo4TGV2RnIyOEd0TC16cDR1eDBBUl9WNHZhZVVMQkhzQjRSZzlCR1BUOWJfaUpzaXVCN1llMXBuLTRqY0RuaHpVaGx6NllUd25LbDhxc1pEQ3RaVHVnZlBKSmNhb19mQTZTcXp4NEM2R2t6c1E?oc=5", "source_name": "Market source", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "PYC Therapeutics (ASX:PYC) Eases While Holding on to Positive One-Year Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQM3FXb3c4OHFPZjFaRWhKRTJOUGxIcHhUT3VTYUVIbzRvWFpDWWVCdlFsb2lSZDZVVlotUXBERU1lWHc3MVRfam41RkxyV3gtZ2s4Y19hck1pdEI5WGxsSTNodmNpb0hWZGdwRmgweUtQY0E5N2NLanM5bGZsb1dGU2lyTFJrcURmWF8zdGJGX0pjVF9kZ25qN1RXM3lsM2xCYkNZRUpTWjZ6S0NwZlJEU2ltZ1Q?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T10:09:00+00:00", "published_display": "14 Jul 2026 10:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC) Slips as Investors Assess the Emerging RNA-Therapeutics Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOE1kY29pX01CTnZzN0VfcnlsZmxodjEwTFZJeHprNFdFc3RWTFhpV182clNDVFk2NDN5bHBEWkpCM1UtQ3dqSk8zSjQ4NTZmNzFTcG1mUVZuazdTRzBqb05sVUNxdXpKdUJCZ1ZLYjBBRDJvckZEVU95b05pTHZYaGZ1c2ZSYVNxXzNtNUlwUlpFaWc0SnlZN0NkSlhTZWNqRGsxZE9rSjA0VEI4LVhybkE3MS0xeXdiaTFsWWQ4d1Y0dw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:16:00+00:00", "published_display": "13 Jul 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC) Names New CFO As Investors Weigh A Pricey Valuation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T23:26:17+00:00", "published_display": "11 Jul 2026 23:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PYC Therapeutics Limited \u2013 ASX:PYC", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQWkQ1akdrQTNCNTVLM3NyZU1JYlZkUnFmN1MxdWxIMzFpNVQwOWRiaWZ2clplUlhSR3VwaU1kZ1hqWFpMV3QxMGoxbmJXNDhqV244NzA5VHN6dVdOWUFYWDVWdG9Hd3JIa0VHaG16ZWNlc0I4aHhwVDhueXlxNlU1eGxVTzdvV3Z0T0FuYW04Yk9VNmJUTF8wT3dmVWM?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T19:24:55+00:00", "published_display": "09 Jul 2026 19:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can PYC Therapeutics (ASX:PYC) Strengthen Its Growth Strategy With a New CFO?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNDFPWFBmX2czSGRubE5JdkdOZXhRdFVnekZHWVVWLWtwcVRPZkI2MmVjMGFoMFc5R1pIUU56dVl3ZkwtVWNUTWtNYVE3VHJ3V3h3WDZIdU1kaWhpYWMtZ1ZHX0l0bW5YT1VmNXFqVkZ2d2dSV3JKRFVLVUFxN0NVR1NjSlptY2VSeHJpXzJ5aFhTaU16Y3QzaFRSZGJOU2N2OHF0ZGJuczVkY0wzcmJJa1RsaWswRUlPRFZN?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-09T03:59:00+00:00", "published_display": "09 Jul 2026 03:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will PYC Therapeutics\u2019 New CFO Shift Its Capital-Market Ambitions Up a Gear (ASX:PYC)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T16:36:12+00:00", "published_display": "08 Jul 2026 16:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyc Therapeutics Limited Announces Appointment of Thomas Ulmer as Chief Financial Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPQzdOdmQ1aXVQVHRiN0tFVzZBWDBaMk1uRHFQLTdWZGVkWk5jZEFuWEhqQTl6RURDOWZ1LVNJaU5tcFREbnEzcUREdGJFOFpZSkN3QThNMmpTT05oNUZkc1gwNl9pYjZzN2dLUElUcTJzc0JGZWJuYUdVVFREeGhscjAwVkl1STZveDZUQkZ3U3NlNDkyYkNoaFRnLW5jTjlJYmdmYWtYdGtNSExoekRRTlp0LVZjeXJfbGFjUmVXaUVQVW45elFwX0ItMnY1al9XTG5UR0xmRHd3Zw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-06T22:21:00+00:00", "published_display": "06 Jul 2026 22:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC) Shares Ease Lower Amid Biotech Sector Watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQ1UxZlhfMk1LVlpQREh0akNTR2pORmNYcE9qZ1pac1hEUVNzU1FNNUp6TVJ4dVVpMXJaM1hRREJLQS1WN0t6SnNCc0c1ZEwxTlNySGZPMXc5M2NpU2xHNTlicE1KNXJKLVJQZHRieGItNVVseDI3QVZ6UlBHMkp5MGhLajlEa3ZKRWRtMW9jUFpWUmhQeC02eUo1Z1J3Y3Z1eWlnODRIMlNzZw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics Limited Actuals & Estimates (ASX:PYC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPQ1k3aDB4QnNuckVfQzd1cmtDVm1ZOTlDdUZSOEE2X2xMandRWGlsM0R3MnNPN0tFWkExeVdDbE9Zc3VQWXV1MXloMDZvQzVYcU5IeWhCam9pa1ZxOHNaZ3NwZTZvYWVMNkY2ak4tZXEtQ0ctOWtObjJGRFlxczI1Ug?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T17:43:44+00:00", "published_display": "25 Jun 2026 17:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pleasing Signs As A Number Of Insiders Buy PYC Therapeutics Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxObnZBY3ZfS0FsMElvSUJnZWRoRUN6MWJJd2tWLVNyUWgtUy1mejJwWUduRk8yOS1Gcy1CWU1Vb3MxQjRsMTdzMllqTEd4N0xqc0hYVktkaGVaQmNCd2xueGZGVVZ3cmhmalhNNzBiRVdSZWF6cmRZbjVNTVpydHlDOXV2ZWlZSXpka3o0Z2hQM2t0NHQ3cTJwb1NIdHBUZEpBbnNqLVZGVlM1YmFtUG05UWFKcExySUV3RnBKNWpBWXRtWkdudEpaeHJCc29sOWdVQlptR3hxZWUwQ1Y1eXE1cnBTZDhjVFHSAewBQVVfeXFMUFBRQWtXMzNjbzEyczlONDFQVUg0a05CTG9NdUtvOFBSeWQzcFJsVmdvVGllSUU0QUctazF0alczMXRXbU05S0R1X0pVS0UwYVJLeVVNZHF5M3B4bUdTWTZwbk5PVjdicTJCZTJoSVN5NHRvVEFkNzVzUkI1V1E4WE1DcWV6V1Noc1NqWE12VWtwU2JnYkE3RUdBTzdmdHhWYVh0WUsyVGZldEFrMmlCVk5UYXAzVEplejFDWVNiMWUxVlpaQ3B5SGVBOGJMai1uY3ZIWExRUmg2Nmk5eVgweVlOdGp6VHYtR2xUdjA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics Announces Company Secretary Changes, Effective June 15, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPRktmeEQtREZrV3RReV81dzdxNmVlMWFxYllOX0FRSjA0Z2l6Q0h0SUMwVktodjN0OFhBZk9iSUI1ZlF3Ny1tUkpaNUs2UUk1WjY2R3F4WHA3bWhPbVBzYUc4TngxN0NUcmJaLTFueUpwOHZGRm80QW9KNGNDRG13a2M1U2dSNjJQb0NfTGxDTENvcUdldHFNYVNueTFva0EzU3RQZVUxQlQtRjlfUmE4S0dzTDNXNVVaLUdUbXhXc2tURXpCbUFJ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics H1 2026 Losses Highlight Ongoing Investment And Test Bullish Profitability Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics (ASX:PYC): Its been raising ~$650m to fund 4 clinical assets for multiple years!", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPOTlQcUtjQ3QyaEVOMTJUemdXTGNHcngxaVpiQUhfWkg3LXcxekdtb19FN1hFSVBxOHNFS0F1c0V5UWk0U2wyOXItZTFOVHVMZDktU21lOGhhYldYOWJYOGdIOGRTbE81TTZqTklkR3g1VWVUVnF0ZkpQcERGUWVDaDh0SEpTN2VpX21HWWQzMXBCTi10N24yWDdCLUVxckxiM2g4WjJ1NGM3OVZXWUtObmV0MWx6TG12X0dj?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC\u2019s capital raise marks one of the largest biotech fundraisings in Australian market history", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNQTBIMi1NZC05YjE5QXVyeDJHVVRvS3dOVjdEWElBNkdhN3B1WWNzdzdKcUx0V1Z5MGZvVU1DNDFFX3JTS1A4R01nelRyOXFzVEQ2RVUzZmxWd09yZWZYRXptV3hwaE4wZGNMUlBzMDhsbFRuNFlLMWRWMWpVN2tlV09zZUs3LWM5MnlrVzdCcjFiYWZZcGVnNDdUT3d2aDBNX2RtLXV3eHVBV0hSSklSbGM5S2xpX0s1cEwzaUx5YUJZLVFNeF9VRw?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Therapeutics launches $600m-plus cash call, hires two banks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPMURPOE1xbGxBaVhGR0I3TnhFVm1lQXR0bFpHSHlHc1dIZURCZm9QVkFzWmVCdS12T1kwSWxuZlg5Q01ac241bnhsVHQyTHZ2dm5pRVozYXFKUUowRnByaWtBMjZjR1o3d3N2SzQ5YmNfU3FUZmNlOE8zMy1EVXdhX0paWWNObjI5enNxdWFiT0JRTU5nZGwwc0ZGMU5kd2dGbEd5RTZWSVJRdw?oc=5", "source_name": "AFR", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Check: PYC Therapeutics kicks off monster $650m capital raising", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQamtrUVpKTFRfY0tpbVFSM2djSFJsdVMxa2FvczY5YXhzVkd5Z1k5aU1JaDJoZjhQVDYtbGNFYk1uTmw1UGxrV19COTYteGU4TnJLVW9vMHBORzJ4SkhWZHExMnNVZFB0RlU1SUVWanBzUERlRkdkQ2VjLVhqVTBLam1CMlQxWG9WblFzdXc0cVktWnEyVWVFdWpPOUdYZU5sMFVrc2oxQzlMRzNp?oc=5", "source_name": "Stockhead", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYC Stock Price and Chart \u2014 ASX:PYC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBmTENuNnhmckUxSE00cExZQzVRamNaVDZ1bjVjX0JrZzJ4cFpkSlhGeFpQc3pYWHBiaVY4eS1HcXpRNVBIWDE2U1pzVXkxbEVpQThvN21fSQ?oc=5", "source_name": "TradingView", "published_at": "2026-01-24T08:00:00+00:00", "published_display": "24 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "When Will PYC Therapeutics Limited (ASX:PYC) Become Profitable?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPemktMUwwQW90OWZiamtsdmFocVlUeldnalVlOG9ka3owZklpNFRGQnZ6SGxEc3ZKVmh1cGRKb1E1a194ZVlvdF9CMGFXSFJWSUQ0NmtGd0dPTzBvRGtsM0h5UFZZTzUzRVR2OU9MQjNwcUlnNjdfeHI3THV3dXJCY0VKLTk?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Breakeven On The Horizon For PYC Therapeutics Limited (ASX:PYC)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-24T08:00:00+00:00", "published_display": "24 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why PYC Therapeutics (ASX:PYC) Is Down 14.4% After Sudden CEO Exit and Board Reshuffle", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBXTVJPWFpoNWhHcVo4TGV2RnIyOEd0TC16cDR1eDBBUl9WNHZhZVVMQkhzQjRSZzlCR1BUOWJfaUpzaXVCN1llMXBuLTRqY0RuaHpVaGx6NllUd25LbDhxc1pEQ3RaVHVnZlBKSmNhb19mQTZTcXp4NEM2R2t6c1E?oc=5", "source_name": "Market source", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 81, "total_relevant": 20, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 15, "score": 53, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 9.9, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 1.55, "latest_week": "2026-07-10", "one_week_move": 1.3, "four_week_move": 27.5, "twelve_week_move": 21.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.700891, "market_dynamics_buy_signal": false, "relative_strength": 13.914668, "fair_value_gap": 31.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 40.7439, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.3% over one week, +27.5% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 5}, {"label": "Kalkine", "count": 3}, {"label": "TradingView", "count": 3}, {"label": "marketscreener.com", "count": 2}, {"label": "Market source", "count": 2}, {"label": "Kalkine Media", "count": 1}, {"label": "Stocks Down Under", "count": 1}, {"label": "BiotechDispatch", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.3% over one week, +27.5% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "PYC Therapeutics (ASX:PYC) Eases While Holding on to Positive One-Year Returns"}], "updated_at": "2026-07-18T05:50:49.637278+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}